Bausch Health Board Authorizes Up to US$50 Million Share Repurchase Program

• Bausch Health's board authorized a common share repurchase program of up to US$ 50 million to manage potential employee equity compensation dilution.
• Repurchases may begin November 3, 2026; the program will end no later than November 3, 2027.
• Purchases cannot exceed 5% of the 374,266,716 common shares outstanding as of October 23, 2026.
• All repurchased common shares will be canceled; the program may be suspended, modified or discontinued at any time.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bausch Health Companies Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NY82760) on October 28, 2026, and is solely responsible for the information contained therein.